PNOC017: BGB-290 with Temozolomide in Adolescent and Young Adult IDH1/2 ND and Recurrent Glioma
Who Can Participate in the Study?
Age Group
Both
Study Details
Full Title
A Target Validation/Phase1 Study of BGB-290 in Combination with Temozolomide in
Adolescent and Young Adult IDH1/2 Newly Diagnosed and Recurrent Mutant Gliomas
Adolescent and Young Adult IDH1/2 Newly Diagnosed and Recurrent Mutant Gliomas
Principal Investigator
Associate Professor of Pediatrics
Protocol Number
IRB:
PRO00111760
NCT:
NCT03749187
Phase
Phase
I
ClinicalTrials.gov
View on ClinicalTrials.gov
Enrollment Status
OPEN TO ACCRUAL